Smith & Nephew (SNN) Amortization of Deferred Charges (2018 - 2024)

Smith & Nephew (SNN) posted quarterly Amortization of Deferred Charges of $61.0 million for Q4 2024, up 38.64% year-on-year from $44.0 million in Q1 2024, and up 38.64% on a QoQ basis from $44.0 million in Q4 2023.

Smith & Nephew (SNN) Amortization of Deferred Charges (2018 - 2024) Analysis & Trends

Smith & Nephew (SNN) has reported Amortization of Deferred Charges for 7 consecutive years, with $61.0 million the latest figure, recorded in Q4 2024.

  • Quarterly Amortization of Deferred Charges rose 38.64% year-over-year to $61.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $176.0 million (up 29.41% YoY) and the FY2025 annual result came in at $112.0 million, down 7.44% from the prior year.
  • Amortization of Deferred Charges grew to $61.0 million in Q4 2024 per SNN's latest filing, from $44.0 million in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for SNN reached as high as $61.0 million in Q4 2024 and fell as low as $21.0 million in Q4 2020.
  • A 5-year average of $39.4 million and a median of $39.0 million in 2021 frame the typical range for Amortization of Deferred Charges.
  • Annual changes were most pronounced in 2021 — Amortization of Deferred Charges jumped 85.71% — and 2022, when it decreased 17.95%.
  • Year by year, Amortization of Deferred Charges stood at $21.0 million in 2020, then jumped by 85.71% to $39.0 million in 2021, then fell by 17.95% to $32.0 million in 2022, then jumped by 37.5% to $44.0 million in 2023, then surged by 38.64% to $61.0 million in 2024.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $61.0 million, $44.0 million, and $32.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 61.00 Mn
Dec 31, 2024 61.00 Mn
Dec 31, 2023 44.00 Mn
Dec 31, 2023 44.00 Mn
Dec 31, 2022 32.00 Mn
Dec 31, 2022 32.00 Mn
Dec 31, 2021 39.00 Mn
Dec 31, 2021 39.00 Mn
Dec 31, 2020 21.00 Mn
Dec 31, 2020 21.00 Mn
Dec 31, 2019 25.00 Mn
Dec 31, 2019 25.00 Mn
Dec 31, 2018 51.00 Mn
Dec 31, 2018 51.00 Mn